Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
IconOVir Bio
AddedFeb 17, 2024
UpdatedJun 18, 2026
IconOVir Bio

IconOVir Bio

Series A

IconOVir Bio: A preclinical biotech firm innovating personalized oncolytic virus cancer therapies.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to cure cancer and restore life to every patient, IconOVir Bio is a preclinical-stage biotechnology company focused on developing advanced oncolytic virus therapies. The company aims to overcome the limitations of earlier generations of oncolytic viruses, providing personalized cancer treatments. IconOVir Bio's innovative platform is designed to enhance the efficacy and specificity of these therapies, offering new hope for patients battling cancer.

IconOVir Bio has attracted notable investors and industry experts who believe in its potential to revolutionize cancer treatment. While still in the preclinical stage, the company has made significant strides in developing its proprietary oncolytic virus platform. Its impact lies in the promise of more effective and personalized cancer therapies, potentially transforming the landscape of oncology and improving patient outcomes worldwide.

IconOVir Bio - Similar Companies

Unleash Immuno Oncolytics logo

Unleash Immuno Oncolytics

unleash.bio

Vyriad logo

Vyriad

vyriad.com

Virion Therapeutics logo

Virion Therapeutics

viriontx.com

Humane Genomics logo

Humane Genomics

humanegenomics.com

Dnatrix logo

Dnatrix

dnatrix.com

Viriom logo

Viriom

viriom.com

OncoMyx Therapeutics logo

OncoMyx Therapeutics

oncomyx.com

Cynvec logo

Cynvec

cynvec.com

Precision Virologics logo

Precision Virologics

Imanis Life Sciences logo

Imanis Life Sciences

imanislife.com

Toragen logo

Toragen

toragen.com

Viracta Therapeutics logo

Viracta Therapeutics

viracta.com

Nextbiotics logo

Nextbiotics

next-biotics.com

Oncolix logo

Oncolix

OncoPrecision logo

OncoPrecision

oncoprecision.bio

IconOVir Bio - Quick Facts

Who are IconOVir Bio's competitors?

Companies similar to IconOVir Bio include Unleash Immuno Oncolytics, Vyriad, Virion Therapeutics and Humane Genomics.

When was IconOVir Bio founded?

IconOVir Bio was founded in 2018.

Where is IconOVir Bio's headquarters located?

IconOVir Bio's headquarters is located in San Diego, CA, US.

When was IconOVir Bio's last funding round?

IconOVir Bio's most recent funding round was for $77M (USD) in January 2021.

How much has IconOVir Bio raised to-date?

As of Jan 5, 2021, IconOVir Bio has raised a total of $77M (USD).

How many employees does IconOVir Bio have?

IconOVir Bio has 8 employees as of Feb 4, 2024.

IconOVir Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncolytic Virus
Tags
  • Biotech
  • Healthcare
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research